is bpc 157 approved in other countries BPC-157 – Research Peptide BPC-157: Interesting Biology, Limited Clinical

Extracellular Matrix Signaling Evaluated in laboratory environments for interactions with signaling pathways and peptide-mediated gene expression models

We induced abdominal compartment syndrome (intra-abdominal pressure in thiopental-anesthetized rats at 25 mmHg (60 min), 30 mmHg (30 min), 40 mmHg (30 min), and 50 mmHg (15 min) and in esketamine-anesthetized rats (25 mmHg for 120 min)) as a model of multiple occlusion syndrome

2011 Mar 14;88(11-12):535-42

This peptide is engineered to disrupt the interaction between the transcription factor FOXO4 and the tumor suppressor protein p53, a key regulatory pathway involved in senescent cell survival